Rationale for Preparing Partially Purified Cancer Vaccines From Shed Antigens Partially purified cancer vaccines address the most essential requirements of cancer vaccines: the need to include ...
• This study aimed to investigate the immunophenotype of esophageal cancer (ESCA) by assessing the patient’s immune defenses or autoimmune function and to identify potential tumor antigens and ...
PHILADELPHIA -- (Jan. 24, 2019) -- Wistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against unique combinations ...
In a recent study published in Nature Machine Intelligence, a team of researchers used a deep antibody-antigen interaction (DeepAAI) algorithm to understand the antibody representations of unseen ...
Cancer is a target-rich environment, but the targets can be hard to see. Even when cancer cells display antigens that are recognized by immune cells—as is evident when an immune cell receptor ...
Amid an evolving landscape of anticancer agents, numerous approaches to elicit tumor-specific immune responses are under active investigation. In broad terms, these approaches have traditionally ...
HELSINKI, Finland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces it is the first biotech company in Europe to ...
Is knowledge of the chemical structure of a novel antigen sufficient to satisfy the written description requirement of claims directed to a genus of antibodies when the antibodies are further defined ...
Correlation between expression of p53, EGFR, cell proliferation defined by Ki67, and survival in stage III/IV non-small cell lung cancer (NSCLC) No significant financial relationships to disclose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results